scispace - formally typeset
S

Sandy L. Nguyen

Researcher at Northwestern University

Publications -  22
Citations -  1074

Sandy L. Nguyen is an academic researcher from Northwestern University. The author has contributed to research in topics: Melanoma & Semiconductor. The author has an hindex of 14, co-authored 22 publications receiving 1017 citations. Previous affiliations of Sandy L. Nguyen include University of California, Los Angeles & Northwest University (United States).

Papers
More filters
Journal ArticleDOI

Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy

TL;DR: In this article, the authors hypothesized that methylation of tumor-related genes detected in serum DNA could predict disease outcome and therapeutic response in patients receiving concurrent biochemotherapy (BC) for metastatic melanoma.
Journal ArticleDOI

Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.

TL;DR: These studies show expression and functional activity of specific TLRs on melanoma cells and as potential therapeutic targets to control tumor progression.
Journal ArticleDOI

Preparation and properties of metallic, superhard rhenium diboride crystals.

TL;DR: Thermogravimetric analysis indicates that the crystals are stable in air up to 1000 degrees C due to the formation of a protective boron oxide coating and four-probe electrical resistivity measurements demonstrate that ReB(2) is the hardest material known to exhibit metallic behavior.
Journal ArticleDOI

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

TL;DR: Significant differences in tumor-related gene methylation patterns relevant to ER and HER2/neu status of breast tumors are demonstrated and may be of significance in the assessment of targeted therapy resistance related to ER-positive and ER-negative status in breast cancer patients.
Journal ArticleDOI

Estrogen receptor-α methylation predicts melanoma progression

TL;DR: Serum methylated ER-α is a significant factor in melanoma progression and was the only factor predicting progression-free and overall survival in biochemotherapy patients and sera is an unfavorable prognostic factor.